Published in Lung on June 12, 2007
Oxidative damage to nucleic acids in severe emphysema. Chest (2008) 1.10
Alveolar epithelial and endothelial cell apoptosis in emphysema: what we know and what we need to know. Int J Chron Obstruct Pulmon Dis (2009) 1.00
Proteomic analyses of human plasma: Venus versus Mars. Transfusion (2011) 0.95
Transcription factor PrtT controls expression of multiple secreted proteases in the human pathogenic mold Aspergillus fumigatus. Infect Immun (2009) 0.95
Alpha-1-antitrypsin therapy ameliorates acute colitis and chronic murine ileitis. Inflamm Bowel Dis (2013) 0.86
Proteostasis strategies for restoring alpha1-antitrypsin deficiency. Proc Am Thorac Soc (2010) 0.84
Role of LTB₄ in the pathogenesis of elastase-induced murine pulmonary emphysema. Am J Physiol Lung Cell Mol Physiol (2010) 0.83
Pilot analysis of the plasma metabolite profiles associated with emphysematous Chronic Obstructive Pulmonary Disease phenotype. Biochem Biophys Res Commun (2011) 0.80
Acquired alpha 1-antitrypsin deficiency in tropical pulmonary eosinophilia. Indian J Med Res (2011) 0.76
Chitosan-genipin nanohydrogel as a vehicle for sustained delivery of alpha-1 antitrypsin. Res Pharm Sci (2016) 0.75
Functional and genomic analyses reveal an essential coordination between the unfolded protein response and ER-associated degradation. Cell (2000) 13.44
Cell migration, chimerism, and graft acceptance. Lancet (1992) 12.24
Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis. Cell (1990) 9.21
Adenovirus-mediated transfer of a recombinant alpha 1-antitrypsin gene to the lung epithelium in vivo. Science (1991) 6.28
The mechanism of Z alpha 1-antitrypsin accumulation in the liver. Nature (1992) 5.71
Liver disease in alpha1-antitrypsin deficiency detected by screening of 200,000 infants. N Engl J Med (1976) 4.39
A regulatory link between ER-associated protein degradation and the unfolded-protein response. Nat Cell Biol (2000) 3.65
Natural history and life expectancy in severe alpha1-antitrypsin deficiency, Pi Z. Acta Med Scand (1978) 3.58
The serpin superfamily of proteinase inhibitors: structure, function, and regulation. J Biol Chem (1994) 3.07
Risk of cirrhosis and primary liver cancer in alpha 1-antitrypsin deficiency. N Engl J Med (1986) 2.84
Replacement therapy for alpha 1-antitrypsin deficiency associated with emphysema. N Engl J Med (1987) 2.81
Sustained secretion of human alpha-1-antitrypsin from murine muscle transduced with adeno-associated virus vectors. Proc Natl Acad Sci U S A (1998) 2.80
A novel signal transduction pathway from the endoplasmic reticulum to the nucleus is mediated by transcription factor NF-kappa B. EMBO J (1995) 2.31
Degradation of a mutant secretory protein, alpha1-antitrypsin Z, in the endoplasmic reticulum requires proteasome activity. J Biol Chem (1996) 2.19
Elastase in tissue injury. Annu Rev Med (1985) 2.16
Alpha1-antitrypsin deficiency--a model for conformational diseases. N Engl J Med (2002) 2.11
Worldwide racial and ethnic distribution of alpha1-antitrypsin deficiency: summary of an analysis of published genetic epidemiologic surveys. Chest (2002) 2.10
Liver transplantation for advanced liver disease with alpha-1-antitrypsin deficiency. N Engl J Med (1980) 2.00
Smoking, lung function, and alpha 1-antitrypsin deficiency. Lancet (1985) 1.99
The liver in adolescents with alpha 1-antitrypsin deficiency. Hepatology (1995) 1.95
Alpha1-antitrypsin and its deficiency. Am Rev Respir Dis (1974) 1.93
Alpha 1 antitrypsin deficiency: the clinical and physiological features of pulmonary emphysema in subjects homozygous for Pi type Z. A survey by the British Thoracic Association. Br J Dis Chest (1983) 1.91
A lag in intracellular degradation of mutant alpha 1-antitrypsin correlates with the liver disease phenotype in homozygous PiZZ alpha 1-antitrypsin deficiency. Proc Natl Acad Sci U S A (1994) 1.91
Z alpha1-antitrypsin polymerizes in the lung and acts as a neutrophil chemoattractant. Chest (2004) 1.88
Adeno-associated virus: integration at a specific chromosomal locus. Curr Opin Genet Dev (1993) 1.87
Orthotopic liver transplantation in children: two-year experience with 47 patients. Pediatrics (1984) 1.86
Variants of alpha 1-antitrypsin in Puerto Rican children with asthma. Chest (1993) 1.75
Efficient gene transfer into nondividing cells by adeno-associated virus-based vectors. J Virol (1994) 1.63
The isolation of a clone for human alpha 1-antitrypsin and the detection of alpha 1-antitrypsin in mRNA from liver and leukocytes. Biochem Biophys Res Commun (1983) 1.62
Clinical features and history of the destructive lung disease associated with alpha-1-antitrypsin deficiency of adults with pulmonary symptoms. Am Rev Respir Dis (1988) 1.58
Liver, lung and malignant disease in heterozygous (Pi MZ) alpha1-antitrypsin deficiency. Acta Med Scand (1975) 1.55
Phase I trial of intramuscular injection of a recombinant adeno-associated virus alpha 1-antitrypsin (rAAV2-CB-hAAT) gene vector to AAT-deficient adults. Hum Gene Ther (2004) 1.54
Activation of endoplasmic reticulum-specific stress responses associated with the conformational disease Z alpha 1-antitrypsin deficiency. J Immunol (2004) 1.53
1 -Antitrypsin deficiency: a variant with no detectable 1 -antitrypsin. Science (1973) 1.53
The natural history of liver disease in alpha 1-antitrypsin deficient children. Acta Paediatr Scand (1988) 1.53
The proteasome participates in degradation of mutant alpha 1-antitrypsin Z in the endoplasmic reticulum of hepatoma-derived hepatocytes. J Biol Chem (2001) 1.49
Lung polymers in Z alpha1-antitrypsin deficiency-related emphysema. Am J Respir Cell Mol Biol (1998) 1.47
Processing by endoplasmic reticulum mannosidases partitions a secretion-impaired glycoprotein into distinct disposal pathways. J Biol Chem (2000) 1.45
Replacement therapy of alpha 1-antitrypsin deficiency. Reversal of protease-antiprotease imbalance within the alveolar structures of PiZ subjects. J Clin Invest (1981) 1.41
Alpha 1-antitrypsin deficiency and emphysema caused by homozygous inheritance of non-expressing alpha 1-antitrypsin genes. N Engl J Med (1986) 1.41
Survival and FEV1 decline in individuals with severe deficiency of alpha1-antitrypsin. The Alpha-1-Antitrypsin Deficiency Registry Study Group. Am J Respir Crit Care Med (1998) 1.40
Polymers of Z alpha1-antitrypsin co-localize with neutrophils in emphysematous alveoli and are chemotactic in vivo. Am J Pathol (2005) 1.36
Multiple tissues express alpha 1-antitrypsin in transgenic mice and man. J Clin Invest (1988) 1.34
6-mer peptide selectively anneals to a pathogenic serpin conformation and blocks polymerization. Implications for the prevention of Z alpha(1)-antitrypsin-related cirrhosis. J Biol Chem (2001) 1.31
Clonal gene therapy: transplanted mouse fibroblast clones express human alpha 1-antitrypsin gene in vivo. Science (1987) 1.30
Pathogenesis of chronic liver injury and hepatocellular carcinoma in alpha-1-antitrypsin deficiency. Pediatr Res (2006) 1.30
Rationale and design of the National Emphysema Treatment Trial (NETT): A prospective randomized trial of lung volume reduction surgery. J Thorac Cardiovasc Surg (1999) 1.29
Cell-specific expression of alpha 1-antitrypsin in human intestinal epithelium. J Clin Invest (1993) 1.23
Polymers of alpha(1)-antitrypsin are chemotactic for human neutrophils: a new paradigm for the pathogenesis of emphysema. Am J Respir Cell Mol Biol (2002) 1.21
Thirteen-year experience in lung transplantation for emphysema. Ann Thorac Surg (2002) 1.21
Outcome of liver disease associated with alpha 1 antitrypsin deficiency (PiZ). Implications for genetic counselling and antenatal diagnosis. Arch Dis Child (1983) 1.17
Unilateral lung transplantation in end-stage pulmonary emphysema. Am Rev Respir Dis (1989) 1.16
Progress of emphysema in severe alpha 1-antitrypsin deficiency as assessed by annual CT. Acta Radiol (1997) 1.15
Alpha-1-antitrypsin deficiency. High prevalence in the St. Louis area determined by direct population screening. Am Rev Respir Dis (1989) 1.15
Young adults with alpha 1-antitrypsin deficiency identified neonatally: their health, knowledge about and adaptation to the high-risk condition. Acta Paediatr (1997) 1.14
Lung function, smoking and survival in severe alpha 1-antitrypsin deficiency, PiZZ. J Clin Epidemiol (1988) 1.12
Anti-neutrophil-elastase defenses of the lower respiratory tract in alpha 1-antitrypsin deficiency directly augmented with an aerosol of alpha 1-antitrypsin. Ann Intern Med (1989) 1.12
The effect of augmentation therapy on bronchial inflammation in alpha1-antitrypsin deficiency. Am J Respir Crit Care Med (2002) 1.12
Strong link between the alpha 1-antitrypsin PiZ allele and Wegener's granulomatosis. J Intern Med (1994) 1.12
Biosynthesis of alpha1-proteinase inhibitor by human lung-derived epithelial cells. J Biol Chem (1997) 1.09
The inhibitory complex of human alpha 1-proteinase inhibitor and human leukocyte elastase is a neutrophil chemoattractant. J Exp Med (1988) 1.08
Aerosol and intravenous transfection of human alpha 1-antitrypsin gene to lungs of rabbits. Am J Respir Cell Mol Biol (1994) 1.08
Gene regulation of the serine proteinase inhibitors alpha1-antitrypsin and alpha1-antichymotrypsin. Biochem Soc Trans (2002) 1.08
Serum alpha 1-antitrypsin deficiency associated with the common S-type (Glu264----Val) mutation results from intracellular degradation of alpha 1-antitrypsin prior to secretion. J Biol Chem (1989) 1.06
Structural explanation for the deficiency of S alpha 1-antitrypsin. Nat Struct Biol (1996) 1.04
Short-term reproducibility of computed tomography-based lung density measurements in alpha-1 antitrypsin deficiency and smokers with emphysema. Acta Radiol (2004) 1.04
Alpha 1-antitrypsin deficiency: evaluation of bronchiectasis with CT. Radiology (1996) 1.01
Alpha-1-antitrypsin deficiency and panniculitis. Perspectives on disease relationship and replacement therapy. Am J Med (1988) 1.01
Liver disease in alpha-1-antitrypsin deficiency: prognostic indicators. J Pediatr (1990) 1.00
Bronchiectasis in patients with alpha 1-antitrypsin deficiency. A rare occurrence? Chest (1993) 0.98
Inhibition of intracellular degradation increases secretion of a mutant form of alpha1-antitrypsin associated with profound deficiency. J Clin Invest (1998) 0.98
The natural history of air-flow obstruction in PiZ emphysema. Report of an NHLBI workshop. Am Rev Respir Dis (1983) 0.98
Risk for liver disease in adults with alpha 1-antitrypsin deficiency. Am J Med (1983) 0.97
Alpha 1-antitrypsin and protease complexation is induced by lipopolysaccharide, interleukin-1beta, and tumor necrosis factor-alpha in monocytes. Am J Respir Crit Care Med (1998) 0.97
3-Hydroxy-3-methylglutaryl-coenzyme A reductase and T cell receptor alpha subunit are differentially degraded in the endoplasmic reticulum. J Biol Chem (1992) 0.96
Screening for alpha1-Pi deficiency in patients with lung diseases. Eur Respir J (2002) 0.94
The protease-antiprotease balance within the human lung: implications for the pathogenesis of emphysema. Lung (1990) 0.94
Inhibition of human leukocyte elastase (HLE) by N-substituted peptidyl trifluoromethyl ketones. J Med Chem (1992) 0.94
Hepatocyte ultrastructural changes in alpha1-antitrypsin deficiency. Gastroenterology (1974) 0.94
Detection of circulating and endothelial cell polymers of Z and wild type alpha 1-antitrypsin by a monoclonal antibody. J Biol Chem (2002) 0.93
Alpha 1-antitrypsin deficiency: the radiological features of pulmonary emphysema in subjects of Pi type Z and Pi type SZ: a survey by the British Thoracic Association. Clin Radiol (1982) 0.93
A future for neonatal alpha1-antitrypsin screening? Acta Paediatr (2000) 0.93
Long-term follow-up of a cohort of children with alpha-1-antitrypsin deficiency. J Pediatr (1990) 0.92
Familial conformational diseases and dementias. Hum Mutat (2002) 0.91
Recombinant DNA-produced alpha 1-antitrypsin administered by aerosol augments lower respiratory tract antineutrophil elastase defenses in individuals with alpha 1-antitrypsin deficiency. J Clin Invest (1989) 0.91
Pulmonary deposition and clearance of aerosolized alpha-1-proteinase inhibitor administered to dogs and to sheep. J Clin Invest (1989) 0.91
Long-term results after lung volume reduction surgery in patients with alpha1-antitrypsin deficiency. J Thorac Cardiovasc Surg (2004) 0.89
High resolution computed tomography (HRCT) in emphysema associated with alpha-1-antitrypsin deficiency. Clin Radiol (1992) 0.89
Oncostatin M is a potent stimulator of alpha1-antitrypsin secretion in lung epithelial cells: modulation by transforming growth factor-beta and interferon-gamma. Am J Respir Cell Mol Biol (1998) 0.87
Morbidity, mortality, and early results of single versus bilateral lung transplantation for emphysema. J Thorac Cardiovasc Surg (1992) 0.87
Hepatic gene therapy: efficient retroviral-mediated gene transfer into rat hepatocytes in vivo. Somat Cell Mol Genet (1993) 0.86
alpha-1-Antitrypsin phenotypes in hepatocellular carcinoma. Hepatology (1982) 0.86
alpha1-Antitrypsin deficiency . 6: new and emerging treatments for alpha1-antitrypsin deficiency. Thorax (2004) 0.86
Decline in pulmonary function in patients with alpha 1-antitrypsin deficiency. Lung (1990) 0.86
Cost-effectiveness analysis of augmentation therapy for severe alpha1-antitrypsin deficiency. Am J Respir Crit Care Med (2003) 0.85
Alpha 1-antitrypsin deficiency and liver disease: clinical presentation, diagnosis and treatment. J Inherit Metab Dis (1991) 0.85
Leukocyte kinetics in the human lung: role of exercise and catecholamines. J Appl Physiol Respir Environ Exerc Physiol (1984) 0.84
Emphysema induced in vitro and in vivo in dogs by a purified elastase from homologous leukocytes. Am Rev Respir Dis (1981) 0.83
A canine model for production of severe unilateral panacinar emphysema. Exp Lung Res (2004) 0.82
Simvastatin decreases lipopolysaccharide-induced pulmonary inflammation in healthy volunteers. Am J Respir Crit Care Med (2009) 2.52
Z alpha1-antitrypsin polymerizes in the lung and acts as a neutrophil chemoattractant. Chest (2004) 1.88
TLR-induced inflammation in cystic fibrosis and non-cystic fibrosis airway epithelial cells. J Immunol (2005) 1.67
Endotoxin up-regulates interleukin-18: potential role for gram-negative colonization in sarcoidosis. Am J Respir Crit Care Med (2005) 1.57
Activation of endoplasmic reticulum-specific stress responses associated with the conformational disease Z alpha 1-antitrypsin deficiency. J Immunol (2004) 1.53
miR-31 dysregulation in cystic fibrosis airways contributes to increased pulmonary cathepsin S production. Am J Respir Crit Care Med (2014) 1.45
Neutrophil elastase up-regulates interleukin-8 via toll-like receptor 4. FEBS Lett (2003) 1.38
Loss of microbicidal activity and increased formation of biofilm due to decreased lactoferrin activity in patients with cystic fibrosis. J Infect Dis (2004) 1.25
Respiratory epithelial cells require Toll-like receptor 4 for induction of human beta-defensin 2 by lipopolysaccharide. Respir Res (2005) 1.21
Activation of the epidermal growth factor receptor (EGFR) by a novel metalloprotease pathway. J Biol Chem (2008) 1.20
Secretory leucoprotease inhibitor impairs Toll-like receptor 2- and 4-mediated responses in monocytic cells. Infect Immun (2004) 1.20
Antimicrobial proteins and polypeptides in pulmonary innate defence. Respir Res (2006) 1.18
Neutrophil elastase up-regulates cathepsin B and matrix metalloprotease-2 expression. J Immunol (2007) 1.17
SLPI and elafin: multifunctional antiproteases of the WFDC family. Biochem Soc Trans (2011) 1.12
Decreased levels of secretory leucoprotease inhibitor in the Pseudomonas-infected cystic fibrosis lung are due to neutrophil elastase degradation. J Immunol (2009) 1.07
Elafin, an elastase-specific inhibitor, is cleaved by its cognate enzyme neutrophil elastase in sputum from individuals with cystic fibrosis. J Biol Chem (2008) 1.03
Elafin prevents lipopolysaccharide-induced AP-1 and NF-kappaB activation via an effect on the ubiquitin-proteasome pathway. J Biol Chem (2006) 1.00
Evaluation of the ability of LL-37 to neutralise LPS in vitro and ex vivo. PLoS One (2011) 0.95
Tauroursodeoxycholic acid inhibits apoptosis induced by Z alpha-1 antitrypsin via inhibition of Bad. Hepatology (2007) 0.95
Innate host defense functions of secretory leucoprotease inhibitor. Exp Lung Res (2007) 0.94
Gentamicin-loaded nanoparticles show improved antimicrobial effects towards Pseudomonas aeruginosa infection. Int J Nanomedicine (2012) 0.93
The prevalence of alpha-1 antitrypsin deficiency in Ireland. Respir Res (2011) 0.93
Biologic protease inhibitors as novel therapeutic agents. Biochimie (2010) 0.89
Impaired immune tolerance to Porphyromonas gingivalis lipopolysaccharide promotes neutrophil migration and decreased apoptosis. Infect Immun (2010) 0.89
Functional study of elafin cleaved by Pseudomonas aeruginosa metalloproteinases. Biol Chem (2010) 0.88
Secretory leucocyte protease inhibitor inhibits interferon-gamma-induced cathepsin S expression. J Biol Chem (2007) 0.86
Delivery of rSLPI in a liposomal carrier for inhalation provides protection against cathepsin L degradation. J Microencapsul (2009) 0.85
Antiproteases as therapeutics to target inflammation in cystic fibrosis. Open Respir Med J (2010) 0.84
Neutrophil elastase increases airway epithelial nonheme iron levels. Clin Transl Sci (2009) 0.84
Neutrophil elastase up-regulates human beta-defensin-2 expression in human bronchial epithelial cells. FEBS Lett (2003) 0.81
Effect of pro-inflammatory stimuli on mucin expression and inhibition by secretory leucoprotease inhibitor. Cell Microbiol (2006) 0.80
The effect of recombinant human lactoferrin on growth and the antibiotic susceptibility of the cystic fibrosis pathogen Burkholderia cepacia complex when cultured planktonically or as biofilms. J Antimicrob Chemother (2007) 0.80
Viral inhibition of IL-1- and neutrophil elastase-induced inflammatory responses in bronchial epithelial cells. J Immunol (2005) 0.79
Altered Toll-like receptor 2-mediated endotoxin tolerance is related to diminished interferon beta production. J Biol Chem (2011) 0.79
Proteolytic cleavage of elafin by 20S proteasome may contribute to inflammation in acute lung injury. Thorax (2012) 0.78
The role of whey acidic protein four-disulfide-core proteins in respiratory health and disease. Biol Chem (2016) 0.75